Bergeron M, Evans S M, Sharp F R, Koch C J, Lord E M, Ferriero D M
Department of Neurology, University of California at San Francisco, 94143-0114, USA.
Neuroscience. 1999;89(4):1357-66. doi: 10.1016/s0306-4522(98)00377-7.
The hypoxia-dependent activation of nitroheterocyclic drugs by cellular nitroreductases leads to the formation of intracellular adducts between the drugs and cellular macromolecules. Because this covalent binding is maximal in the absence of oxygen, detection of bound adducts provides an assay for estimating the degree of cellular hypoxia in vivo. Using a pentafluorintated derivative of etanidazole called EF5, we studied the distribution of EF5 adducts in seven-day-old rats subjected to different treatments which decrease the level of oxygen in the brain. EF5 solution was administered intraperitoneally 30 min prior to each treatment. The effect of acute and chronic hypoxia on EF5 adduct formation (binding) was studied in the brain of newborn rats exposed to global hypoxia (8% O2 for 30, 90 or 150 min) and in the brain of chronically hypoxic rat pups with congenital cardiac defects (Wistar Kyoto). The effect of combined hypoxia-ischemia was investigated in rat pups subjected to right carotid coagulation and concurrent exposure to 8% O2 for 30, 90 or 150 min. Brains were frozen immediately at the end of each treatment. Using a Cy3-conjugated monoclonal mouse antibody (ELK3-51) raised against EF5 adducts, hypoxic cells within brain regions were visualized by fluorescence immunocytochemistry. Brains from controls or vehicle-injected animals showed no EF5 binding. Notably, brains from animals which were chronically hypoxemic as a result of congenital cardiac defects also showed no EF5 binding. A short exposure (30 min) to hypoxia or to combined hypoxia-ischemia resulted in increased background stain and few scattered cells with low-intensity immunostaining. Acute hypoxia exposure of at least 90-150 min, which in this age animal does not result in frank cellular damage, produced patchy areas of low- to moderate-intensity fluorescence scattered throughout the brain. In contrast, 90-150 min of hypoxia-ischemia was associated with intense immunofluorescence in the hemisphere ipsilateral to the carotid occlusion, with a pattern similar to that reported previously for the histological damage seen in this model. This study provides a sensitive method for the evaluation of the level of oxygen depletion in brain tissue after neonatal hypoxia-ischemia at times much earlier than any method demonstrates apoptotic or necrotic cell death Since the level of in vivo formation of macromolecular adducts of EF5 depends on the degree of oxygen depletion in a tissue, intracellular EF5 binding may serve as a useful marker of regional cellular vulnerability and redox state after brain injury resulting from hypoxia-ischemia.
细胞硝基还原酶对硝基杂环药物的缺氧依赖性激活导致药物与细胞大分子之间形成细胞内加合物。由于这种共价结合在无氧条件下最大,因此检测结合的加合物可提供一种在体内估计细胞缺氧程度的测定方法。我们使用一种名为EF5的乙硝唑五氟衍生物,研究了EF5加合物在接受不同降低脑内氧水平处理的7日龄大鼠中的分布。在每次处理前30分钟腹腔注射EF5溶液。在暴露于全身性缺氧(8%氧气,持续30、90或150分钟)的新生大鼠脑内以及患有先天性心脏缺陷(Wistar Kyoto)的慢性缺氧幼鼠脑内,研究了急性和慢性缺氧对EF5加合物形成(结合)的影响。在接受右颈动脉结扎并同时暴露于8%氧气30、90或150分钟的幼鼠中,研究了缺氧缺血联合作用的影响。在每次处理结束时立即将脑冷冻。使用针对EF5加合物产生的Cy3偶联单克隆小鼠抗体(ELK3 - 51),通过荧光免疫细胞化学观察脑区内的缺氧细胞。来自对照或注射赋形剂动物的脑未显示EF5结合。值得注意的是,由于先天性心脏缺陷导致慢性低氧血症的动物的脑也未显示EF5结合。短时间暴露(30分钟)于缺氧或缺氧缺血联合作用导致背景染色增加和少数散在的低强度免疫染色细胞。至少90 - 150分钟的急性缺氧暴露,在这个年龄段的动物中不会导致明显的细胞损伤,会在整个脑内产生散在的低至中等强度荧光斑块区域。相比之下,90 - 150分钟的缺氧缺血与颈动脉闭塞同侧半球的强烈免疫荧光相关,其模式与先前报道的该模型中所见的组织学损伤相似。这项研究提供了一种敏感的方法,用于评估新生儿缺氧缺血后脑组织中氧耗竭水平,时间比任何显示凋亡或坏死细胞死亡的方法都要早得多。由于EF5的大分子加合物在体内的形成水平取决于组织中的氧耗竭程度,细胞内EF5结合可作为缺氧缺血性脑损伤后区域细胞易损性和氧化还原状态的有用标记。